Incyte’s Oral JAK1 Inhibitor Shows Potential In Facial, Full Body Vitiligo

 
• By Joseph Haas
  
Vitiligo
Incyte is hoping to bring vitiligo patients multiple therapeutic options • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D